Skip to content
Open access

VARION: A Network Propagation Framework for Individual Patient Somatic Mutation Interpretation in Cancer Molecular Subtyping

Sep 2026 · bioRxiv · 0 citations
Biology

TL;DR

Results indicate that VARION’s GIS-weighted centroid architecture enables individual-patient molecular subtyping that outperforms existing NBS and graph-learning clustering approaches, with high sensitivity for clinically actionable rare subtypes and robust cross- platform generalization.

Read PDF

Similar papers

Sep 2026

RCoxNet: A Deep Learning Framework Integrating Random Walk with Restart, Mutation, and Clinical Data for Cancer Survival Prediction.

Accurate survival prediction in cancer remains challenging due to the sparsity of somatic mutation profiles and the failure of existing models to capture higher-order gene-gene dependencies. Network diffusion methods such as Random Walk with Restart (RWR) can propagate mutation signals across protein-protein interactio...

Stuti Kumari, Sakshi Gujral, Abhishek Halder et al. · 0 citations
#graph neural networks Open access Sep 2026

Heterogeneous graph neural networks with biological prior knowledge for interpretable drug repurposing in triple-negative breast cancer

Drug repurposing offers a cost-effective path to new therapies for triple-negative breast cancer (TNBC), a subtype with limited targeted treatment options. We present PRECISION, a framework integrating transcription factor (TF) regulatory networks, protein-protein interactions, and drug-target edges into a heterogeneou...

C. Fernandez-Lozano, David Ferreiro, Patricia V.-del-Río · 0 citations
Aug 2026

A Network-Guided Modular Framework for drug response prediction in acute myeloid leukemia.

NGM-AML, a modular model predicting ex vivo drug response from BeatAML2 RNA-seq and sensitivity data, achieves mean Pearson and Spearman correlations of 0.324 and 0.326 across drugs, consistent with known AML survival and drug-resistance mechanisms.

Yu-Rung Wu, Yuan Wang, Wen-Jia Zhao et al. · 0 citations
Review Open access Sep 2026

Molecular therapy matching score correlates with clinical outcomes: a system for navigating cancer complexity

An algorithmic Matching Score is described that evaluates cancer drugs’/drug combinations’ ability to address a patients’ entire next-generation sequencing/multi-omic-derived molecular profile and underscores the clinical importance of the precision medicine approach that maximizes matching of multiple molecular altera...

Ally Perlina, Subha Krishnan, K. Bush et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.